149 institutions hold shares in Wave Life Sciences Ltd. (WVE), with 6.35M shares held by insiders accounting for 12.97% while institutional investors hold 88.14% of the company’s shares. The shares outstanding are 48.85M, and float is at 39.95M with Short Float at 10.47%. Institutions hold 76.71% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is RA Capital Management, L.P. with over 7.78 million shares valued at $61.19 million. The investor’s holdings represent 15.87% of the WVE Shares outstanding. As of Dec 30, 2020, the second largest holder is Primecap Management Company with 3.92 million shares valued at $30.89 million to account for 8.01% of the shares outstanding. The other top investors are Nantahala Capital Management, LLC which holds 3.36 million shares representing 6.85% and valued at over $26.42 million, while Blackrock Inc. holds 6.17% of the shares totaling 3.03 million with a market value of $23.81 million.
Wave Life Sciences Ltd. (NASDAQ: WVE) is -9.91% lower on its value in year-to-date trading and has touched a low of $6.76 and a high of $19.98 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The WVE stock was last observed hovering at around $7.35 in the last trading session, with the day’s loss setting it -0.26% off its average median price target of $20.00 for the next 12 months. It is also 73.74% off the consensus price target high of $27.00 offered by 8 analysts, but current levels are -1.29% lower than the price target low of $7.00 for the same period.
Currently trading at $7.09, the stock is -24.70% and -28.19% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.93 million and changing -3.54% at the moment leaves the stock -27.40% off its SMA200. WVE registered -23.19% loss for a year compared to 6-month gain of -23.48%. The firm has a 50-day simple moving average (SMA 50) of $9.78 and a 200-day simple moving average (SMA200) of $9.50.
The stock witnessed a -24.65% loss in the last 1 month and extending the period to 3 months gives it a -20.43%, and is -32.67% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.95% over the week and 9.45% over the month.
Wave Life Sciences Ltd. (WVE) has around 217 employees, a market worth around $357.27M and $20.10M in sales. Distance from 52-week low is 4.88% and -64.51% from its 52-week high. The company has generated returns on investments over the last 12 months (-184.20%).
Wave Life Sciences Ltd. (WVE) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Wave Life Sciences Ltd. (WVE) is a “Overweight”. 8 analysts offering their recommendations for the stock have an average rating of 2.40, where 4 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Wave Life Sciences Ltd. is expected to release its quarterly report on 05/12/2021 and quarterly earnings per share for the current quarter are estimated at -$0.54 with sales reaching $12M over the same period.The EPS is expected to grow by 33.20% this year, but quarterly earnings will post 253.30% year-over-year. Quarterly sales are estimated to grow 188.40% in year-over-year returns.
Wave Life Sciences Ltd. (WVE) Insider Activity
A total of 11 insider transactions have happened at Wave Life Sciences Ltd. (WVE) in the last six months, with sales accounting for 5 and purchases happening 6 times. The most recent transaction is an insider sale by Francis Chris. SEC filings show that Francis Chris sold 2,698 shares of the company’s common stock on Feb 16 at a price of $10.57 per share for a total of $28518.0. Following the sale, the insider now owns 78462.0 shares.
Wave Life Sciences Ltd. disclosed in a document filed with the SEC on Feb 16 that BOLNO PAUL (President and CEO) sold a total of 11,205 shares of the company’s common stock. The trade occurred on Feb 16 and was made at $10.57 per share for $0.12 million. Following the transaction, the insider now directly holds 0.41 million shares of the WVE stock.
Still, SEC filings show that on Feb 16, Panzara Michael A. disposed off 2,929 shares at an average price of $10.57 for $30960.0. The insider now directly holds 86,420 shares of Wave Life Sciences Ltd. (WVE).
Wave Life Sciences Ltd. (WVE): Who are the competitors?
The company’s main competitors (and peers) include NextEra Energy Inc. (NEE) that is trading 28.99% up over the past 12 months and Wave Life Sciences Ltd. (WVE) that is -23.19% lower over the same period. Short interest in the company’s stock has fallen -4.78% from the last report on Feb 11, 2021 to stand at a total of 4.38 million short shares sold with a short interest ratio of 6.54.